These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9383 related articles for article (PubMed ID: 2076865)

  • 1. Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis.
    Blessing K; McLaren KM; McLean A; Davidson P
    Histopathology; 1990 Nov; 17(5):389-95. PubMed ID: 2076865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of thin (< 1.5 mm) malignant melanomas with poor prognosis.
    Park KG; Blessing K; McLaren KM; Watson AC
    Br J Plast Surg; 1993 Oct; 46(7):607-10. PubMed ID: 8252271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thick malignant melanomas (greater than 3 mm Breslow) with good clinical outcome: a histological study and survival analysis.
    Blessing K; McLaren KM; McLean A; Davidson P
    Histopathology; 1991 Feb; 18(2):143-8. PubMed ID: 2010179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.
    Kalady MF; White RR; Johnson JL; Tyler DS; Seigler HF
    Ann Surg; 2003 Oct; 238(4):528-35; discussion 535-7. PubMed ID: 14530724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thin malignant melanomas.
    Boi S; Barbareschi M; Zumianai G; Cristofolini M
    Histopathology; 1991 Jul; 19(1):100-1. PubMed ID: 1916683
    [No Abstract]   [Full Text] [Related]  

  • 8. Sentinel node biopsy improves prognostic stratification in patients with thin (pT1) melanomas and an additional risk factor.
    Mitteldorf C; Bertsch HP; Jung K; Thoms KM; Schön MP; Tronnier M; Kretschmer L
    Ann Surg Oncol; 2014 Jul; 21(7):2252-8. PubMed ID: 24652352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Thin" malignant melanoma: risk factors and clinical management.
    Slingluff CL; Seigler HF
    Ann Plast Surg; 1992 Jan; 28(1):89-94. PubMed ID: 1642416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience of thin cutaneous melanomas (less than 0.76 mm and less than 0.85 mm thick) in a large plastic surgery unit: a 5 to 17 year follow-up.
    Briggs JC; Ibrahim NB; Hastings AG; Griffiths RW
    Br J Plast Surg; 1984 Oct; 37(4):501-6. PubMed ID: 6498388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
    Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
    J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thin malignant melanomas with regression and metastases.
    Ronan SG; Eng AM; Briele HA; Shioura NN; Das Gupta TK
    Arch Dermatol; 1987 Oct; 123(10):1326-30. PubMed ID: 3662564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An epidemiological study of the distinct histological types of cutaneous melanoma in relation to other variables of the disease].
    Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Agudo Ferrándiz J; Segarra Castelló L
    Rev Clin Esp; 1992 Mar; 190(4):169-76. PubMed ID: 1589611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regressing thin malignant melanoma: a distinctive lesion with metastatic potential.
    Gromet MA; Epstein WL; Blois MS
    Cancer; 1978 Nov; 42(5):2282-92. PubMed ID: 719608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases.
    Guitart J; Lowe L; Piepkorn M; Prieto VG; Rabkin MS; Ronan SG; Shea CR; Tron VA; White W; Barnhill RL
    Arch Dermatol; 2002 May; 138(5):603-8. PubMed ID: 12020220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal "thin" malignant melanoma. Identifying patients at risk.
    Slingluff CL; Vollmer RT; Reintgen DS; Seigler HF
    Ann Surg; 1988 Aug; 208(2):150-61. PubMed ID: 3401060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence potential of thin primary melanomas.
    Naruns PL; Nizze JA; Cochran AJ; Lee MB; Morton DL
    Cancer; 1986 Feb; 57(3):545-8. PubMed ID: 3942987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression in malignant melanoma. A histologic feature without independent prognostic significance.
    Kelly JW; Sagebiel RW; Blois MS
    Cancer; 1985 Nov; 56(9):2287-91. PubMed ID: 4052972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator.
    Kelly JW; Sagebiel RW; Clyman S; Blois MS
    Ann Surg; 1985 Jul; 202(1):98-103. PubMed ID: 4015217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 470.